# Nonacus

> Nonacus is a VC fund in Birmingham backing Health Care and Biotechnology. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Birmingham, United Kingdom
- Total investments: 1
- Last investment: Mar 2023
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/nonacus-ltd/about
- X (Twitter): https://twitter.com/nonacusltd
- Website: https://nonacus.com
- Facebook: https://www.facebook.com/nonacusltd

Nonacus is a medical products manufacturing company that offers non-invasive diagnostic tools.

## Contacts

5 contacts available for Nonacus. Shizune tracks 2 team members at Nonacus. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/nonacus?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Andrew Feber | Clinical Director of Research and Development | 0 | https://shizune.co/investors/profile/andrew-feber |
| Samuel Clokie | Director Of Bioinformatics & Data Science | 0 | https://shizune.co/investors/profile/samuel-clokie |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| CanSense | CanSense is a developer of an inexpensive and scalable blood test intended for early diagnosis of bowel cancer. | $1.8M | Seed | Mar 08, 2023 |  |

1 of 1 investments shown.

## Co-investors
- [Development Bank of Wales](https://shizune.co/investors/profile/development-bank-of-wales) — VC Fund, 1 deal together
- [Mercia Fund Managers](https://shizune.co/investors/profile/mercia-fund-management) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Nonacus invest in?

Nonacus invests primarily in Health Care, Biotechnology and Health Diagnostics startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Nonacus?

Public channels for Nonacus include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Nonacus?

The team at Nonacus includes Andrew Feber (Clinical Director of Research and Development) and Samuel Clokie (Director Of Bioinformatics & Data Science). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co